Efficacy and safety of omalizumab in Japanese and Korean patients with refractory chronic spontaneous urticaria

ダウンロード数 : ? 件

この文献の参照には次のURLをご利用ください : https://ir.lib.shimane-u.ac.jp/53336

言語	英語
著者	Michihiro Hide Department of Dermatology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan Hae-Sim Park Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea Atsuyuki Igarashi Department of Dermatology, NTT Medical Center Tokyo, Tokyo, Japan Young-Min Ye Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea Tae-Bum Kim Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Akiko Yagami Department of Dermatology, Fujita Health University School of Medicine, Toyoake, Japan Jooyoung Roh Department of Dermatology, Gachon University Gil Medical Center, Incheon, Korea Jae-Hyun Lee Department of Internal Medicine, Institute of Allergy, Yonsei University College of Medicine, Seoul, Korea 千貫祐子医学部 Woong Youn Sang Department of Dermatology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea Soo-Keol Lee Department of Internal Medicine, Dong-A University School of Medicine, Busan, Korea Naoko Inomata Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan Jeong-Hee Choi Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea Atsushi Fukunaga Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan Junyi Wang Novartis Pharma K.K., Tokyo, Japan Soichiro Matsushima Novartis Pharma K.K., Tokyo, Japan Steve Greenberg Novartis Pharmaceutical Corporation, East Hanover, NJ, USA Sam Khalil Novartis Pharma AG, Basel, Switzerland
主題	Antihistamines; Chronic spontaneous urticaria; Japan; Korea; Omalizumab
掲載誌名	JOURNAL OF DERMATOLOGICAL SCIENCE
巻	87
号	1
開始ページ	70
終了ページ	78
ISSN	0923-1811
ISSN（Online）	1873-569X
発行日	2017-07
DOI	10.1016/j.jdermsci.2017.03.009
PubMed ID	28366435
出版者	ELSEVIER IRELAND LTD
資料タイプ	学術雑誌論文
部局	医学部
備考	This study was funded by Novartis Pharmaceuticals.